Clinical Trials Sponsored by Ottawa Heart Institute Research Corporation

Total 1518 results

Ottawa Heart Institute Research Corporation

Not yet recruiting

Exercise Testing Protocols for Females and Males With CAD (PACED)

Coronary Artery Disease
Ottawa Heart Institute Research Corporation

Not yet recruiting

Dapagliflozin in STEMI Randomized Clinical Trial (DAPA STEMI)

Myocardial Infarction | ST Elevation Myocardial Infarction

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users (VC-OMSC)

Tobacco Smoking | Vaping
Ottawa Heart Institute Research Corporation

Recruiting

Exercise Training in Women With Cardiac Devices (CIED-EX)

Cardiovascular Diseases

Canada
Ottawa Heart Institute Research Corporation

Recruiting

An Interactive Smartphone Application to Motivate Smokers to Quit (StepOne)

Smoking Cessation | Smoking Behaviors

Canada
Ottawa Heart Institute Research Corporation

Recruiting

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock (DOREMI-2)

Shock, Cardiogenic

United States, Canada
Ottawa Heart Institute Research Corporation

Recruiting

QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT) (QOL-CAFRCT)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation (ACUTE-AF)

Atrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry (COVID-VIHPR)

Myocarditis | Pericarditis

Canada
Ottawa Heart Institute Research Corporation

Completed

Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias

Arrythmia

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

The COVID-RASi Trial (COVID-19)

Cardiovascular Diseases | COVID-19

Brazil, Canada, Mexico
Ottawa Heart Institute Research Corporation

Suspended

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND (RAPID EXTEND)

Myocardial Infarction | Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Enrolling by invitation

Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment (TRIGISTRY)

Tricuspid Regurgitation

United States, Spain, Israel, Canada, France, Germany, Netherlands, Switzerland, Austria, Italy
Ottawa Heart Institute Research Corporation

Completed

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses (WALK)

Cardiovascular Diseases | Cardiovascular Risk Factor

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Feasibility of Transepicardial Atrial Injection

Cardiac Surgery

Canada
Ottawa Heart Institute Research Corporation

Completed

Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study

Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (CAPITAL PCI AF)

Atrial Fibrillation | Acute Coronary Syndrome

Canada
Ottawa Heart Institute Research Corporation

Completed

Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure

Heart Failure

Canada
Ottawa Heart Institute Research Corporation

Completed

Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation (PREHAB HTx Study) (PREHAB)

Heart Failure

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

Coronary Artery Disease | Diabetes Mellitus
Ottawa Heart Institute Research Corporation

Terminated

Optimization of SPECT Imaging (OSCARS)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Terminated

Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention (AVATAR)

Ventricular Tachycardia | Ventricular Arrhythmia

Canada
Ottawa Heart Institute Research Corporation

Completed

Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients

Stroke

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Cardiac Sarcoidosis Response To Steroids Trial (CASTOR)

Sarcoidosis | Cardiac Sarcoidosis

Canada
Ottawa Heart Institute Research Corporation

Completed

Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty

Platelet Reactivity

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Blood Flow Reserve: Effects After Training With Heavy Inspiratory Exercises (BREATHE)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease (HIIT-NoW)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Evaluating the Use of a Remote Telehome Monitoring Hypertension Program for Patients Receiving Virtual Care (HTMTHM)

Hypertension

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation (VirtualEX)

Cardiac Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery (LENIENT)

Post-Op Complication

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Exercise Training in Women With Heart Disease (EXCEED)

Cardiovascular Diseases | Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus (LACLOT)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation Symptoms (Glucose-AF)

Atrial Fibrillation | Type 2 Diabetes

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Healing Hearts Together: Evaluating a Couples-based Intervention to Improve Health Outcomes

Cardiovascular Diseases

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

Radial Artery Occlusion

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training (NEURO-AF)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

Impact of Preoperative FFR on Arterial Bypass Graft Functionality (IMPAG)

Heart Disease

Canada, Belgium
Ottawa Heart Institute Research Corporation

Active, not recruiting

The RAPID COVID-19 TRIAGE Algorithm

COVID-19

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

Barrier-Protect Study

Infection

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

IMAGE-HF: Project IIa Canadian CArdiomyopathy Registry for Device Therapy (CanCARD-MR)

Heart Failure
Ottawa Heart Institute Research Corporation

Completed

Spironolactone Therapy in Chronic Stable Right HF Trial (STAR-HF)

Pulmonary Arterial Hypertension | Pulmonary Hypertension, Primary, 4 | Chronic Right-Sided Heart Failure | Pulmonary Hypertension, Primary, 2 | Pulmonary Hypertension, Primary, 3 | Cardiomyopathy Right Ventricular

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Surgical PA-LAA Shunting: a Feasibility Study (PA-LAA)

LAA Thrombus Prevention

Canada
Ottawa Heart Institute Research Corporation

Completed

Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs (OMSCinDEP)

Pre-diabetic | Diabetic Type II Mellitus

Canada
Ottawa Heart Institute Research Corporation

Completed

Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients (CAPITALCHILL)

Cardiac Arrest

Canada
Ottawa Heart Institute Research Corporation

Terminated

Sleep to Your Heart's Content - Insomnia Intervention for Cardiac Patients

Cardiovascular Diseases | Insomnia

Canada
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
Ottawa Heart Institute Research Corporation

Completed

Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator Replacement

Cardiovascular Diseases | Death, Sudden | Death, Sudden, Cardiac

Canada
Ottawa Heart Institute Research Corporation

Terminated

A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease

Pulmonary Hypertension

Canada
Ottawa Heart Institute Research Corporation

Terminated

Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

Myocardial Ischemia

Canada
Ottawa Heart Institute Research Corporation

Completed

Ticagrelor vs Clopidogrel Effect on MFR in CAD Population (PATH)

Coronary Artery Disease

Canada

Clinical Trials Sponsored by Ottawa Heart Institute Research Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations